Regeneron Pharmaceuticals: Truist Securities raises target price to $780 from $772
REGN•Truist Securities raised its target price for Regeneron Pharmaceuticals to $780 from $772.
Related News
Sunrun schedules third-quarter 2026 earnings report and conference call
RUN•
Canadian power mega-deal is a twin momentum trade
EMA•
DXC expands Assure Platform as insurance adoption tops 275 customers
DXC•
Google, Unity partner on AI-driven game creation platform Unity Spark
U•
Jasper Therapeutics announces offer to purchase outstanding warrants
JSPR•